Frontend Software Engineer

We seek a talented and passionate Sr. UI Software Engineer with extensive experience in React.js to join our dynamic team. As a Sr. UI Software Engineer, you will be crucial in designing, developing, and maintaining high-quality web applications. You will collaborate closely with cross-functional teams, including designers, product managers, and backend engineers, to create seamless and engaging user experiences., * Build and maintain user-friendly web applications using React.js, ensuring high performance across various devices and browsers.

• Work closely with UX/UI designers to translate design concepts into functional and visually appealing user interfaces.
• Write clean, maintainable, and well-documented code, following best practices and industry standards
• Create reusable components and front-end libraries for future use.
• Optimize components for maximum performance and responsiveness
• Develop and execute unit tests and collaborate with engineering teams to ensure high-quality

• M.Tech/Master's Degree in Computer Science, Engineering, or a related field; or equivalent practical experience.
• 5 years of professional experience in front-end development.
• Proven experience with React.js and its core principles.
• Proficiency in JavaScript, including DOM manipulation and the JavaScript object model.
• 5 years of experience with React.js and its lifecycle methodologies (e.g., Class Components, Functional Components, Hooks).
• Experience with state management libraries (e.g., Redux, MobX).
• Solid understanding of HTML and CSS, including CSS preprocessors like SASS or LESS.
• Good familiarity with RESTful APIs.
• Good experience with common front-end development tools

Tilda Research, based in San Francisco, is an innovator in clinical research execution. We focus on data integration, site-wide automation and real-time operational metrics to enable faster bench-to-market solutions for our research partners. We operate a growing network of clinical research sites in the US, and our team has worked on over 250 pan-indication Phase I thru IV studies.